310 AI

310 AI is a United States-based company specializing in the development of artificial intelligence technology. With a team of 8 employees, 310 AI is focused on pushing the boundaries of what's possible in the field of biomolecule design. The company's core mission is to create an AI engine capable of designing novel biomolecules, a field they believe will be revolutionized by artificial intelligence in the coming years. 310 AI distinguishes itself through its commitment to leveraging AI for groundbreaking advancements in biomolecule design. Their technology has the potential to significantly impact various industries reliant on biomolecules, such as pharmaceuticals, agriculture, and materials science. For more information about 310 AI and its innovative solutions, visit their website at 310.ai.